Brief: Cyxone Plans To Initiate A Phase 2 Clinical Trial With Rabeximod In COVID-19 Patients

Cyxone AB

14/09/2020 15:59

Sept 14 (Reuters) - Cyxone AB  CYXO.ST :
    * CYXONE PLANS TO INITIATE A PHASE 2 CLINICAL TRIAL WITH
RABEXIMOD
IN COVID-19 PATIENTS
    * TREATMENT IS INTENDED TO REDUCE RISK OF DEVELOPING SEVERE
RESPIRATORY SYMPTOMS CAUSED BY VIRUS-RELATED OVERACTIVATION OF
IMMUNE SYSTEM.

Source text for Eikon:  ID:nWkr9kCz1d 
Further company coverage:  CYXO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))